Sarepta Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $275M | 2.2M | 124.89 |
| 2024-06-30 | $291M | 1.8M | 158.00 |
| 2024-03-31 | $237M | 1.8M | 129.46 |
| 2023-12-31 | $126M | 1.3M | 96.43 |
| 2023-09-30 | $559M | 4.6M | 121.22 |
| 2023-06-30 | $505M | 4.4M | 114.67 |
| 2023-03-31 | $365M | 3.7M | 100.00 |
| 2022-12-31 | $162M | 1.2M | 129.93 |
| 2022-06-30 | $77M | 1.0M | 74.77 |
| 2022-03-31 | $85M | 1.1M | 77.80 |
| 2021-12-31 | $95M | 1.0M | 90.28 |
| 2021-03-31 | $56M | 754k | 74.70 |
| 2020-12-31 | $129M | 755k | 170.45 |
| 2020-09-30 | $162M | 1.1M | 143.79 |
| 2020-06-30 | $254M | 1.6M | 161.02 |
| 2020-03-31 | $112M | 1.1M | 97.86 |
| 2019-12-31 | $121M | 937k | 129.16 |
| 2019-09-30 | $7.8M | 104k | 75.50 |
| 2019-06-30 | $13M | 98k | 129.51 |
| 2019-03-31 | $26M | 214k | 119.76 |
| 2018-12-31 | $22M | 205k | 108.61 |
| 2018-09-30 | $14M | 86k | 161.51 |
| 2018-06-30 | $27M | 201k | 132.18 |
| 2018-03-31 | $53M | 709k | 74.09 |
| 2017-12-31 | $24M | 435k | 55.65 |
| 2017-06-30 | $9.3M | 276k | 33.71 |
| 2017-03-31 | $4.8M | 162k | 29.60 |
| 2016-12-31 | $1.7M | 64k | 27.44 |
| 2016-09-30 | $4.2M | 69k | 61.42 |
| 2016-06-30 | $11k | 570 | 19.30 |
| 2016-03-31 | $97k | 4.9k | 19.56 |
| 2015-12-31 | $186k | 4.5k | 40.82 |
| 2013-09-30 | $797k | 17k | 46.98 |
| 2013-06-30 | $990k | 26k | 38.23 |